{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:55:37Z","timestamp":1789692937097,"version":"4.0.1"},"reference-count":145,"publisher":"Bentham Science Publishers Ltd.","issue":"22","funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RICET FIS Network: RD12\/0018\/0017"],"award-info":[{"award-number":["RICET FIS Network: RD12\/0018\/0017"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["BIO-199"],"award-info":[{"award-number":["BIO-199"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2019,9,20]]},"abstract":"<jats:sec><jats:title\/><jats:p>Kinetoplastid and apicomplexan parasites comprise a group of protozoans responsible for human diseases, with a serious impact on human health and the socioeconomic growth of developing countries. Chemotherapy is the main option to control these pathogenic organisms and nucleotide metabolism is considered a promising area for the provision of antimicrobial therapeutic targets. Impairment of thymidylate (dTMP) biosynthesis severely diminishes the viability of parasitic protozoa and the absence of enzymatic activities specifically involved in the formation of dTMP (e.g. dUTPase, thymidylate synthase, dihydrofolate reductase or thymidine kinase) results in decreased deoxythymidine triphosphate (dTTP) levels and the so-called thymineless death. In this process, the ratio of deoxyuridine triphosphate (dUTP) versus dTTP in the cellular nucleotide pool has a crucial role. A high dUTP\/dTTP ratio leads to uracil misincorporation into DNA, the activation of DNA repair pathways, DNA fragmentation and eventually cell death. The essential character of dTMP synthesis has stimulated interest in the identification and development of drugs that specifically block the biochemical steps involved in thymine nucleotide formation. Here, we review the available literature in relation to drug discovery studies targeting thymidylate biosynthesis in kinetoplastid (genera Trypanosoma and Leishmania) and apicomplexan (Plasmodium spp and Toxoplasma gondii) protozoans. The most relevant findings concerning novel inhibitory molecules with antiparasitic activity against these human pathogens are presented herein.<\/jats:p><\/jats:sec>","DOI":"10.2174\/0929867325666180926154329","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T11:44:50Z","timestamp":1538048690000},"page":"4262-4279","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Targeting Kinetoplastid and Apicomplexan Thymidylate Biosynthesis as an Antiprotozoal Strategy"],"prefix":"10.2174","volume":"26","author":[{"given":"Mar\u00eda","family":"Valente","sequence":"first","affiliation":[{"name":"Instituto de Parasitologia y Biomedicina \"Lopez-Neyra\", Consejo Superior de Investigaciones Cient\u00edficas, Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio E.","family":"Vidal","sequence":"additional","affiliation":[{"name":"Instituto de Parasitologia y Biomedicina \"Lopez-Neyra\", Consejo Superior de Investigaciones Cient\u00edficas, Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Gonz\u00e1lez-Pacanowska","sequence":"additional","affiliation":[{"name":"Instituto de Parasitologia y Biomedicina \"Lopez-Neyra\", Consejo Superior de Investigaciones Cient\u00edficas, Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0165-1110(94)90006-X","volume":"318","author":"Kunz B.A.","year":"1994","unstructured":"Kunz B.A.; Kohalmi S.E.; Kunkel T.A.; Mathews C.K.; McIntosh E.M.; Reidy J.A.; International commission for protection against environmental mutagens and carcinogens. Deoxyribonucleoside triphosphate levels: a critical factor in the maintenance of genetic stability. Mutat Res 1994,318(1),1-64","journal-title":"Mutat Res"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1146\/annurev.bi.57.070188.002025","volume":"57","author":"Reichard P.","year":"1988","unstructured":"Reichard P.; Interactions between deoxyribonucleotide and DNA synthesis. Annu Rev Biochem 1988,57,349-374","journal-title":"Annu Rev Biochem"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1093\/nar\/gkq829","volume":"39","author":"Kumar D.","year":"2011","unstructured":"Kumar D.; Abdulovic A.L.; Viberg J.; Nilsson A.K.; Kunkel T.A.; Chabes A.; Mechanisms of mutagenesis in vivo due to imbalanced dNTP pools. Nucleic Acids Res 2011,39(4),1360-1371","journal-title":"Nucleic Acids Res"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"18251","DOI":"10.1016\/S0021-9258(19)36949-2","volume":"267","author":"Kunkel T.A.","year":"1992","unstructured":"Kunkel T.A.; DNA replication fidelity. J Biol Chem 1992,267(26),18251-18254","journal-title":"J Biol Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1021\/ar800114w","volume":"42","author":"V\u00e9rtessy B.G.","year":"2009","unstructured":"V\u00e9rtessy B.G.; T\u00f3th J.; Keeping uracil out of DNA: physiological role, structure and catalytic mechanism of dUTPases. Acc Chem Res 2009,42(1),97-106","journal-title":"Acc Chem Res"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1073\/pnas.44.10.1004","volume":"44","author":"Cohen S.S.","year":"1958","unstructured":"Cohen S.S.; Flaks J.G.; Barner H.D.; Loeb M.R.; Lichtenstein J.; The mode of action of 5-Fluorouracil and its derivatives. Proc Natl Acad Sci USA 1958,44(10),1004-1012","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=7","year":"2017","unstructured":"World malaria report WHO(Accessed on 15 March, 2015).2017","journal-title":"World malaria report"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14760584.2017.1333426","volume":"16","author":"Othman A.S.","year":"2017","unstructured":"Othman A.S.; Marin-Mogollon C.; Salman A.M.; Franke-Fayard B.M.; Janse C.J.; Khan S.M.; The use of transgenic parasites in malaria vaccine research. Expert Rev Vaccines 2017,16(7),1-13","journal-title":"Expert Rev Vaccines"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13071-016-1553-y","volume":"9","author":"Srivastava S.","year":"2016","unstructured":"Srivastava S.; Shankar P.; Mishra J.; Singh S.; Possibilities and challenges for developing a successful vaccine for leishmaniasis. Parasit Vectors 2016,9(1),277","journal-title":"Parasit Vectors"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1574-6968.1988.tb02709.x","volume":"4","author":"Hassan H.F.","year":"1988","unstructured":"Hassan H.F.; Coombs G.H.; Purine and pyrimidine metabolism in parasitic protozoa. FEMS Microbiol Rev 1988,4(1),47-83","journal-title":"FEMS Microbiol Rev"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1128\/MMBR.34.3.278-343.1970","volume":"34","author":"O\u2019Donovan G.A.","year":"1970","unstructured":"O\u2019Donovan G.A.; Neuhard J.; Pyrimidine metabolism in microorganisms. Bacteriol Rev 1970,34(3),278-343","journal-title":"Bacteriol Rev"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1079\/PNS19820048","volume":"41","author":"Z\u00f6llner N.","year":"1982","unstructured":"Z\u00f6llner N.; Purine and pyrimidine metabolism. Proc Nutr Soc 1982,41(3),329-342","journal-title":"Proc Nutr Soc"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.femsre.2005.03.004","volume":"29","author":"de Koning H.P.","year":"2005","unstructured":"de Koning H.P.; Bridges D.J.; Burchmore R.J.; Purine and pyrimidine transport in pathogenic protozoa: from biology to therapy. FEMS Microbiol Rev 2005,29(5),987-1020","journal-title":"FEMS Microbiol Rev"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0166-6851(84)90117-8","volume":"13","author":"Hammond D.J.","year":"1984","unstructured":"Hammond D.J.; Gutteridge W.E.; Purine and pyrimidine metabolism in the Trypanosomatidae. Mol Biochem Parasitol 1984,13(3),243-261","journal-title":"Mol Biochem Parasitol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2174\/138945007779315524","volume":"8","author":"Hyde J.E.","year":"2007","unstructured":"Hyde J.E.; Targeting purine and pyrimidine metabolism in human apicomplexan parasites. Curr Drug Targets 2007,8(1),31-47","journal-title":"Curr Drug Targets"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1124\/mol.112.082321","volume":"83","author":"Ali J.A.","year":"2013","unstructured":"Ali J.A.; Creek D.J.; Burgess K.; Allison H.C.; Field M.C.; M\u00e4ser P.; De Koning H.P.; Pyrimidine salvage in Trypanosoma brucei bloodstream forms and the trypanocidal action of halogenated pyrimidines. Mol Pharmacol 2013,83(2),439-453","journal-title":"Mol Pharmacol"},{"key":"ref=17","doi-asserted-by":"publisher","DOI":"10.1002\/9783527694082.ch6","author":"Valente M.V.A.E.G.P.D.","year":"2016","unstructured":"Valente M.V.A.E.G.P.D.; Potential of pyrimidine metabolism for antitrypanosomal drug discovery 2016","journal-title":"Potential of pyrimidine metabolism for antitrypanosomal drug discovery"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1006\/jmbi.1998.2293","volume":"285","author":"Gao G.","year":"1999","unstructured":"Gao G.; Nara T.; Nakajima-Shimada J.; Aoki T.; Novel organization and sequences of five genes encoding all six enzymes for de novo pyrimidine biosynthesis in Trypanosoma cruzi. J Mol Biol 1999,285(1),149-161","journal-title":"J Mol Biol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbrc.2011.12.148","volume":"418","author":"Nara T.","year":"2012","unstructured":"Nara T.; Hashimoto M.; Hirawake H.; Liao C.W.; Fukai Y.; Suzuki S.; Tsubouchi A.; Morales J.; Takamiya S.; Fujimura T.; Taka H.; Mineki R.; Fan C.K.; Inaoka D.K.; Inoue M.; Tanaka A.; Harada S.; Kita K.; Aoki T.; Molecular interaction of the first 3 enzymes of the de novo pyrimidine biosynthetic pathway of Trypanosoma cruzi. Biochem Biophys Res Commun 2012,418(1),140-143","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0020-711X(81)90082-3","volume":"13","author":"Hill B.","year":"1981","unstructured":"Hill B.; Kilsby J.; McIntosh R.T.; Wrigglesworth R.; Ginger C.D.; Pyrimidine biosynthesis in Plasmodium berghei. Int J Biochem 1981,13(3),303-310","journal-title":"Int J Biochem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"6270","DOI":"10.1021\/bi00478a023","volume":"29","author":"Krungkrai J.","year":"1990","unstructured":"Krungkrai J.; Cerami A.; Henderson G.B.; Pyrimidine biosynthesis in parasitic protozoa: purification of a monofunctional dihydroorotase from Plasmodium berghei and Crithidia fasciculata. Biochemistry 1990,29(26),6270-6275","journal-title":"Biochemistry"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2958.2008.06131.x","volume":"68","author":"Arakaki T.L.","year":"2008","unstructured":"Arakaki T.L.; Buckner F.S.; Gillespie J.R.; Malmquist N.A.; Phillips M.A.; Kalyuzhniy O.; Luft J.R.; Detitta G.T.; Verlinde C.L.; Van Voorhis W.C.; Hol W.G.; Merritt E.A.; Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studies. Mol Microbiol 2008,68(1),37-50","journal-title":"Mol Microbiol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.pep.2006.02.010","volume":"48","author":"Feliciano P.R.","year":"2006","unstructured":"Feliciano P.R.; Cordeiro A.T.; Costa-Filho A.J.; Nonato M.C.; Cloning, expression, purification, and characterization of Leishmania major dihydroorotate dehydrogenase. Protein Expr Purif 2006,48(1),98-103","journal-title":"Protein Expr Purif"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0166-6851(02)00100-7","volume":"122","author":"Takashima E.","year":"2002","unstructured":"Takashima E.; Inaoka D.K.; Osanai A.; Nara T.; Odaka M.; Aoki T.; Inaka K.; Harada S.; Kita K.; Characterization of the dihydroorotate dehydrogenase as a soluble fumarate reductase in Trypanosoma cruzi. Mol Biochem Parasitol 2002,122(2),189-200","journal-title":"Mol Biochem Parasitol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"41827","DOI":"10.1074\/jbc.M206854200","volume":"277","author":"Baldwin J.","year":"2002","unstructured":"Baldwin J.; Farajallah A.M.; Malmquist N.A.; Rathod P.K.; Phillips M.A.; Malarial dihydroorotate dehydrogenase. Substrate and inhibitor specificity. J Biol Chem 2002,277(44),41827-41834","journal-title":"J Biol Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.molbiopara.2012.04.009","volume":"184","author":"Hortua Triana M.A.","year":"2012","unstructured":"Hortua Triana M.A.; Huynh M.H.; Garavito M.F.; Fox B.A.; Bzik D.J.; Carruthers V.B.; L\u00f6ffler M.; Zimmermann B.H.; Biochemical and molecular characterization of the pyrimidine biosynthetic enzyme dihydroorotate dehydrogenase from Toxoplasma gondii. Mol Biochem Parasitol 2012,184(2),71-81","journal-title":"Mol Biochem Parasitol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1081\/NCN-200027678","volume":"23","author":"Christopherson R.I.","year":"2004","unstructured":"Christopherson R.I.; Cinquin O.; Shojaei M.; Kuehn D.; Menz R.I.; Cloning and expression of malarial pyrimidine enzymes. Nucleosides Nucleotides Nucleic Acids 2004,23(8-9),1459-1465","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1021\/bi048439h","volume":"44","author":"Krungkrai S.R.","year":"2005","unstructured":"Krungkrai S.R.; DelFraino B.J.; Smiley J.A.; Prapunwattana P.; Mitamura T.; Horii T.; Krungkrai J.; A novel enzyme complex of orotate phosphoribosyltransferase and orotidine 5\u2032-monophosphate decarboxylase in human malaria parasite Plasmodium falciparum: physical association, kinetics, and inhibition characterization. Biochemistry 2005,44(5),1643-1652","journal-title":"Biochemistry"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.bbrc.2004.04.124","volume":"318","author":"Krungkrai S.R.","year":"2004","unstructured":"Krungkrai S.R.; Prapunwattana P.; Horii T.; Krungkrai J.; Orotate phosphoribosyltransferase and orotidine 5\u2032-monophosphate decarboxylase exist as multienzyme complex in human malaria parasite Plasmodium falciparum. Biochem Biophys Res Commun 2004,318(4),1012-1018","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0166-6851(97)00058-3","volume":"87","author":"Carter D.","year":"1997","unstructured":"Carter D.; Donald R.G.; Roos D.; Ullman B.; Expression, purification, and characterization of uracil phosphoribosyltransferase from Toxoplasma gondii. Mol Biochem Parasitol 1997,87(2),137-144","journal-title":"Mol Biochem Parasitol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0304-4165(82)90002-2","volume":"718","author":"Hammond D.J.","year":"1982","unstructured":"Hammond D.J.; Gutteridge W.E.; UMP synthesis in the kinetoplastida. Biochim Biophys Acta 1982,718(1),1-10","journal-title":"Biochim Biophys Acta"},{"key":"ref=32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004882","volume":"11","author":"Srivastava A.","year":"2015","unstructured":"Srivastava A.; Creek D.J.; Evans K.J.; De Souza D.; Schofield L.; M\u00fcller S.; Barrett M.P.; McConville M.J.; Waters A.P.; Host reticulocytes provide metabolic reservoirs that can be exploited by malaria parasites. PLoS Pathog 2015,11(6)","journal-title":"PLoS Pathog"},{"key":"ref=33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004689","volume":"11","author":"Creek D.J.","year":"2015","unstructured":"Creek D.J.; Mazet M.; Achcar F.; Anderson J.; Kim D.H.; Kamour R.; Morand P.; Millerioux Y.; Biran M.; Kerkhoven E.J.; Chokkathukalam A.; Weidt S.K.; Burgess K.E.; Breitling R.; Watson D.G.; Bringaud F.; Barrett M.P.; Probing the metabolic network in bloodstream-form Trypanosoma brucei using untargeted metabolomics with stable isotope labelled glucose. PLoS Pathog 2015,11(3)","journal-title":"PLoS Pathog"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/mmi.13467","volume":"102","author":"Valente M.","year":"2016","unstructured":"Valente M.; Timm J.; Castillo-Acosta V.M.; Ruiz-P\u00e9rez L.M.; Balzarini T.; Nettleship J.E.; Bird L.E.; Rada H.; Wilson K.S.; Gonz\u00e1lez-Pacanowska D.; Cell cycle regulation and novel structural features of thymidine kinase, an essential enzyme in Trypanosoma brucei. Mol Microbiol 2016,102(3),365-385","journal-title":"Mol Microbiol"},{"key":"ref=35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006010","volume":"12","author":"Leija C.","year":"2016","unstructured":"Leija C.; Rijo-Ferreira F.; Kinch L.N.; Grishin N.V.; Nischan N.; Kohler J.J.; Hu Z.; Phillips M.A.; Pyrimidine salvage enzymes are essential for de novo biosynthesis of deoxypyrimidine nucleotides in Trypanosoma brucei. PLoS Pathog 2016,12(11)","journal-title":"PLoS Pathog"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0079-6603(08)60859-4","volume":"48","author":"Mosbaugh D.W.","year":"1994","unstructured":"Mosbaugh D.W.; Bennett S.E.; Uracil-excision DNA repair. Prog Nucleic Acid Res Mol Biol 1994,48,315-370","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"17711","DOI":"10.1073\/pnas.0504643102","volume":"102","author":"Auerbach P.","year":"2005","unstructured":"Auerbach P.; Bennett R.A.; Bailey E.A.; Krokan H.E.; Demple B.; Mutagenic specificity of endogenously generated abasic sites in Saccharomyces cerevisiae chromosomal DNA. Proc Natl Acad Sci USA 2005,102(49),17711-17716","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1073\/pnas.94.7.3290","volume":"94","author":"Blount B.C.","year":"1997","unstructured":"Blount B.C.; Mack M.M.; Wehr C.M.; MacGregor J.T.; Hiatt R.A.; Wang G.; Wickramasinghe S.N.; Everson R.B.; Ames B.N.; Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 1997,94(7),3290-3295","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1079\/PNS2004","volume":"63","author":"Duthie S.J.","year":"2004","unstructured":"Duthie S.J.; Narayanan S.; Sharp L.; Little J.; Basten G.; Powers H.; Folate, DNA stability and colo-rectal neoplasia. Proc Nutr Soc 2004,63(4),571-578","journal-title":"Proc Nutr Soc"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1146\/annurev.micro.52.1.591","volume":"52","author":"Ahmad S.I.","year":"1998","unstructured":"Ahmad S.I.; Kirk S.H.; Eisenstark A.; Thymine metabolism and thymineless death in prokaryotes and eukaryotes. Annu Rev Microbiol 1998,52,591-625","journal-title":"Annu Rev Microbiol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0027-5107(01)00168-3","volume":"480-481","author":"Fenech M.","year":"2001","unstructured":"Fenech M.; Recommended dietary allowances (RDAs) for genomic stability. Mutat Res 2001,480-481,51-54","journal-title":"Mutat Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.biochi.2009.10.008","volume":"92","author":"Quesada-Soriano I.","year":"2010","unstructured":"Quesada-Soriano I.; Casas-Solvas J.M.; Recio E.; Ruiz-P\u00e9rez L.M.; Vargas-Berenguel A.; Gonz\u00e1lez-Pacanowska D.; Garc\u00eda-Fuentes L.; Kinetic properties and specificity of trimeric Plasmodium falciparum and human dUTPases. Biochimie 2010,92(2),178-186","journal-title":"Biochimie"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/355740a0","volume":"355","author":"Cedergren-Zeppezauer E.S.","year":"1992","unstructured":"Cedergren-Zeppezauer E.S.; Larsson G.; Nyman P.O.; Dauter Z.; Wilson K.S.; Crystal structure of a dUTPase. Nature 1992,355(6362),740-743","journal-title":"Nature"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.str.2004.11.015","volume":"13","author":"Whittingham J.L.","year":"2005","unstructured":"Whittingham J.L.; Leal I.; Nguyen C.; Kasinathan G.; Bell E.; Jones A.F.; Berry C.; Benito A.; Turkenburg J.P.; Dodson E.J.; Ruiz Perez L.M.; Wilkinson A.J.; Johansson N.G.; Brun R.; Gilbert I.H.; Gonzalez Pacanowska D.; Wilson K.S.; dUTPase as a platform for antimalarial drug design: structural basis for the selectivity of a class of nucleoside inhibitors. Structure 2005,13(2),329-338","journal-title":"Structure"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.str.2005.06.009","volume":"13","author":"Tarbouriech N.","year":"2005","unstructured":"Tarbouriech N.; Buisson M.; Seigneurin J.M.; Cusack S.; Burmeister W.P.; The monomeric dUTPase from Epstein-Barr virus mimics trimeric dUTPases. Structure 2005,13(9),1299-1310","journal-title":"Structure"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0014-5793(02)03158-7","volume":"526","author":"Bernier-Villamor V.","year":"2002","unstructured":"Bernier-Villamor V.; Camacho A.; Hidalgo-Zarco F.; P\u00e9rez J.; Ruiz-P\u00e9rez L.M.; Gonz\u00e1lez-Pacanowska D.; Characterization of deoxyuridine 5\u2032-triphosphate nucleotidohydrolase from Trypanosoma cruzi. FEBS Lett 2002,526(1-3),147-150","journal-title":"FEBS Lett"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1126\/science.1112642","volume":"309","author":"Berriman M.","year":"2005","unstructured":"Berriman M.; Ghedin E.; Hertz-Fowler C.; Blandin G.; Renauld H.; Bartholomeu D.C.; Lennard N.J.; Caler E.; Hamlin N.E.; Haas B.; B\u00f6hme U.; Hannick L.; Aslett M.A.; Shallom J.; Marcello L.; Hou L.; Wickstead B.; Alsmark U.C.; Arrowsmith C.; Atkin R.J.; Barron A.J.; Bringaud F.; Brooks K.; Carrington M.; Cherevach I.; Chillingworth T.J.; Churcher C.; Clark L.N.; Corton C.H.; Cronin A.; Davies R.M.; Doggett J.; Djikeng A.; Feldblyum T.; Field M.C.; Fraser A.; Goodhead I.; Hance Z.; Harper D.; Harris B.R.; Hauser H.; Hostetler J.; Ivens A.; Jagels K.; Johnson D.; Johnson J.; Jones K.; Kerhornou A.X.; Koo H.; Larke N.; Landfear S.; Larkin C.; Leech V.; Line A.; Lord A.; Macleod A.; Mooney P.J.; Moule S.; Martin D.M.; Morgan G.W.; Mungall K.; Norbertczak H.; Ormond D.; Pai G.; Peacock C.S.; Peterson J.; Quail M.A.; Rabbinowitsch E.; Rajandream M.A.; Reitter C.; Salzberg S.L.; Sanders M.; Schobel S.; Sharp S.; Simmonds M.; Simpson A.J.; Tallon L.; Turner C.M.; Tait A.; Tivey A.R.; Van Aken S.; Walker D.; Wanless D.; Wang S.; White B.; White O.; Whitehead S.; Woodward J.; Wortman J.; Adams M.D.; Embley T.M.; Gull K.; Ullu E.; Barry J.D.; Fairlamb A.H.; Opperdoes F.; Barrell B.G.; Donelson J.E.; Hall N.; Fraser C.M.; Melville S.E.; El-Sayed N.M.; The genome of the African trypanosome Trypanosoma brucei. Science 2005,309(5733),416-422","journal-title":"Science"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1042\/bj3460163","volume":"346","author":"Camacho A.","year":"2000","unstructured":"Camacho A.; Hidalgo-Zarco F.; Bernier-Villamor V.; Ruiz-P\u00e9rez L.M.; Gonz\u00e1lez-Pacanowska D.; Properties of Leishmania major dUTP nucleotidohydrolase, a distinct nucleotide-hydrolysing enzyme in kinetoplastids. Biochem J 2000,346(Pt 1),163-168","journal-title":"Biochem J"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.str.2003.11.016","volume":"12","author":"Harkiolaki M.","year":"2004","unstructured":"Harkiolaki M.; Dodson E.J.; Bernier-Villamor V.; Turkenburg J.P.; Gonz\u00e1lez-Pacanowska D.; Wilson K.S.; The crystal structure of Trypanosoma cruzi dUTPase reveals a novel dUTP\/dUDP binding fold. Structure 2004,12(1),41-53","journal-title":"Structure"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1110\/ps.48801","volume":"10","author":"Hidalgo-Zarco F.","year":"2001","unstructured":"Hidalgo-Zarco F.; Camacho A.G.; Bernier-Villamor V.; Nord J.; Ruiz-Perez L.M.; Gonzalez-Pacanowska D.; Kinetic properties and inhibition of the dimeric dUTPase-dUDPase from Leishmania major. Protein Sci 2001,10,1426-1433","journal-title":"Protein Sci"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1016\/j.biocel.2008.06.009","volume":"40","author":"Castillo-Acosta V.M.","year":"2008","unstructured":"Castillo-Acosta V.M.; Est\u00e9vez A.M.; Vidal A.E.; Ruiz-Perez L.M.; Gonz\u00e1lez-Pacanowska D.; Depletion of dimeric all-alpha dUTPase induces DNA strand breaks and impairs cell cycle progression in Trypanosoma brucei. Int J Biochem Cell Biol 2008,40(12),2901-2913","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molbiopara.2012.11.003","volume":"187","author":"Castillo-Acosta V.M.","year":"2013","unstructured":"Castillo-Acosta V.M.; Aguilar-Pereyra F.; Garc\u00eda-Caballero D.; Vidal A.E.; Ruiz-P\u00e9rez L.M.; Gonz\u00e1lez-Pacanowska D.; Pyrimidine requirements in deoxyuridine triphosphate nucleotidohydrolase deficient Trypanosoma brucei mutants. Mol Biochem Parasitol 2013,187(1),9-13","journal-title":"Mol Biochem Parasitol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"24010","DOI":"10.1074\/jbc.271.39.24010","volume":"271","author":"Larsson G.","year":"1996","unstructured":"Larsson G.; Nyman P.O.; Kvassman J.O.; Kinetic characterization of dUTPase from Escherichia coli. J Biol Chem 1996,271(39),24010-24016","journal-title":"J Biol Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"5942","DOI":"10.1021\/jm050111e","volume":"48","author":"Nguyen C.","year":"2005","unstructured":"Nguyen C.; Kasinathan G.; Leal-Cortijo I.; Musso-Buendia A.; Kaiser M.; Brun R.; Ruiz-P\u00e9rez L.M.; Johansson N.G.; Gonz\u00e1lez-Pacanowska D.; Gilbert I.H.; Deoxyuridine triphosphate nucleotidohydrolase as a potential antiparasitic drug target. J Med Chem 2005,48(19),5942-5954","journal-title":"J Med Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jmb.2005.01.030","volume":"347","author":"Moroz O.V.","year":"2005","unstructured":"Moroz O.V.; Murzin A.G.; Makarova K.S.; Koonin E.V.; Wilson K.S.; Galperin M.Y.; Dimeric dUTPases, HisE, and MazG belong to a new superfamily of all-alpha NTP pyrophosphohydrolases with potential \u201chouse-cleaning\u201d functions. J Mol Biol 2005,347(2),243-255","journal-title":"J Mol Biol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1016\/j.bmcl.2006.04.027","volume":"16","author":"Mc Carthy O.K.","year":"2006","unstructured":"Mc Carthy O.K.; Schipani A.; Buend\u00eda A.M.; Ruiz-Perez L.M.; Kaiser M.; Brun R.; Pacanowska D.G.; Gilbert I.H.; Design, synthesis and evaluation of novel uracil amino acid conjugates for the inhibition of Trypanosoma cruzi dUTPase. Bioorg Med Chem Lett 2006,16(14),3809-3812","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1042\/BJ20130796","volume":"456","author":"Hemsworth G.R.","year":"2013","unstructured":"Hemsworth G.R.; Gonz\u00e1lez-Pacanowska D.; Wilson K.S.; On the catalytic mechanism of dimeric dUTPases. Biochem J 2013,456(1),81-88","journal-title":"Biochem J"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"16470","DOI":"10.1074\/jbc.M111.224873","volume":"286","author":"Hemsworth G.R.","year":"2011","unstructured":"Hemsworth G.R.; Moroz O.V.; Fogg M.J.; Scott B.; Bosch-Navarrete C.; Gonz\u00e1lez-Pacanowska D.; Wilson K.S.; The crystal structure of the Leishmania major deoxyuridine triphosphate nucleotidohydrolase in complex with nucleotide analogues, dUMP, and deoxyuridine. J Biol Chem 2011,286(18),16470-16481","journal-title":"J Biol Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1101\/gr.176401","volume":"11","author":"Brocchieri L.","year":"2001","unstructured":"Brocchieri L.; Low-complexity regions in Plasmodium proteins: in search of a function. Genome Res 2001,11(2),195-197","journal-title":"Genome Res"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1016\/j.ejmech.2011.04.052","volume":"46","author":"Recio E.","year":"2011","unstructured":"Recio E.; Musso-Buend\u00eda A.; Vidal A.E.; Ruda G.F.; Kasinathan G.; Nguyen C.; Ruiz-P\u00e9rez L.M.; Gilbert I.H.; Gonz\u00e1lez-Pacanowska D.; Site-directed mutagenesis provides insights into the selective binding of trityl derivatives to Plasmodium falciparum dUTPase. Eur J Med Chem 2011,46(8),3309-3314","journal-title":"Eur J Med Chem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1021\/jm060126s","volume":"49","author":"Nguyen C.","year":"2006","unstructured":"Nguyen C.; Ruda G.F.; Schipani A.; Kasinathan G.; Leal I.; Musso-Buendia A.; Kaiser M.; Brun R.; Ruiz-P\u00e9rez L.M.; Sahlberg B.L.; Johansson N.G.; Gonzalez-Pacanowska D.; Gilbert I.H.; Acyclic nucleoside analogues as inhibitors of Plasmodium falciparum dUTPase. J Med Chem 2006,49(14),4183-4195","journal-title":"J Med Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.ejmech.2008.05.018","volume":"44","author":"McCarthy O.","year":"2009","unstructured":"McCarthy O.; Musso-Buendia A.; Kaiser M.; Brun R.; Ruiz-Perez L.M.; Johansson N.G.; Pacanowska D.G.; Gilbert I.H.; Design, synthesis and evaluation of novel uracil acetamide derivatives as potential inhibitors of Plasmodium falciparum dUTP nucleotidohydrolase. Eur J Med Chem 2009,44(2),678-688","journal-title":"Eur J Med Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/cmdc.201000445","volume":"6","author":"Ruda G.F.","year":"2011","unstructured":"Ruda G.F.; Nguyen C.; Ziemkowski P.; Felczak K.; Kasinathan G.; Musso-Buendia A.; Sund C.; Zhou X.X.; Kaiser M.; Ruiz-P\u00e9rez L.M.; Brun R.; Kulikowski T.; Johansson N.G.; Gonz\u00e1lez-Pacanowska D.; Gilbert I.H.; Modified 5\u2032-trityl nucleosides as inhibitors of Plasmodium falciparum dUTPase. ChemMedChem 2011,6(2),309-320","journal-title":"ChemMedChem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1016\/j.bmc.2011.02.012","volume":"19","author":"Baraga\u00f1a B.","year":"2011","unstructured":"Baraga\u00f1a B.; McCarthy O.; S\u00e1nchez P.; Bosch-Navarrete C.; Kaiser M.; Brun R.; Whittingham J.L.; Roberts S.M.; Zhou X.X.; Wilson K.S.; Johansson N.G.; Gonz\u00e1lez-Pacanowska D.; Gilbert I.H.; \u03b2-Branched acyclic nucleoside analogues as inhibitors of Plasmodium falciparum dUTPase. Bioorg Med Chem 2011,19(7),2378-2391","journal-title":"Bioorg Med Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1002\/cmdc.201100255","volume":"6","author":"Hampton S.E.","year":"2011","unstructured":"Hampton S.E.; Baraga\u00f1a B.; Schipani A.; Bosch-Navarrete C.; Musso-Buend\u00eda J.A.; Recio E.; Kaiser M.; Whittingham J.L.; Roberts S.M.; Shevtsov M.; Brannigan J.A.; Kahnberg P.; Brun R.; Wilson K.S.; Gonz\u00e1lez-Pacanowska D.; Johansson N.G.; Gilbert I.H.; Design, synthesis, and evaluation of 5\u2032-diphenyl nucleoside analogues as inhibitors of the Plasmodium falciparum dUTPase. ChemMedChem 2011,6(10),1816-1831","journal-title":"ChemMedChem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"5876","DOI":"10.1016\/j.bmc.2013.07.004","volume":"21","author":"Hampton S.E.","year":"2013","unstructured":"Hampton S.E.; Schipani A.; Bosch-Navarrete C.; Recio E.; Kaiser M.; Kahnberg P.; Gonz\u00e1lez-Pacanowska D.; Johansson N.G.; Gilbert I.H.; Investigation of acyclic uridine amide and 5\u2032-amido nucleoside analogues as potential inhibitors of the Plasmodium falciparum dUTPase. Bioorg Med Chem 2013,21(18),5876-5885","journal-title":"Bioorg Med Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1007\/s00044-014-1189-4","volume":"2015","author":"Rodolfo Andr\u00e9 de Ara\u00fajo Santos C.A.B.","year":"2015","unstructured":"Rodolfo Andr\u00e9 de Ara\u00fajo Santos C.A.B.; Jahan B.; Ghasemi, R.S.-S.; Barbosa, E.G. Mixed 2D\u20133D-LQTA-QSAR study of a series of Plasmodium falciparum dUTPase inhibitors. Med Chem Res 2015,2015,1098-1111","journal-title":"Med Chem Res"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/0014-4894(90)90119-W","volume":"70","author":"Ivanetich K.M.","year":"1990","unstructured":"Ivanetich K.M.; Santi D.V.; Thymidylate synthase-dihydrofolate reductase in protozoa. Exp Parasitol 1990,70(3),367-371","journal-title":"Exp Parasitol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1128\/AAC.5.2.169","volume":"5","author":"Amyes S.G.","year":"1974","unstructured":"Amyes S.G.; Smith J.T.; Trimethoprim action and its analogy with thymine starvation. Antimicrob Agents Chemother 1974,5(2),169-178","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-micro-092412-155749","volume":"69","author":"Khodursky A.","year":"2015","unstructured":"Khodursky A.; Guzm\u00e1n E.C.; Hanawalt P.C.; Thymineless Death Lives On: New insights into a classic phenomenon. Annu Rev Microbiol 2015,69,247-263","journal-title":"Annu Rev Microbiol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1021\/bi00410a039","volume":"27","author":"Grumont R.","year":"1988","unstructured":"Grumont R.; Sirawaraporn W.; Santi D.V.; Heterologous expression of the bifunctional thymidylate synthase-dihydrofolate reductase from Leishmania major. Biochemistry 1988,27(10),3776-3784","journal-title":"Biochemistry"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0166-6851(94)90076-0","volume":"65","author":"Reche P.","year":"1994","unstructured":"Reche P.; Arrebola R.; Olmo A.; Santi D.V.; Gonzalez-Pacanowska D.; Ruiz-Perez L.M.; Cloning and expression of the dihydrofolate reductase-thymidylate synthase gene from Trypanosoma cruzi. Mol Biochem Parasitol 1994,65(2),247-258","journal-title":"Mol Biochem Parasitol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0166-6851(95)00059-A","volume":"72","author":"Gamarro F.","year":"1995","unstructured":"Gamarro F.; Yu P.L.; Zhao J.; Edman U.; Greene P.J.; Santi D.; Trypanosoma brucei dihydrofolate reductase-thymidylate synthase: gene isolation and expression and characterization of the enzyme. Mol Biochem Parasitol 1995,72(1-2),11-22","journal-title":"Mol Biochem Parasitol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"7170","DOI":"10.1073\/pnas.88.16.7170","volume":"88","author":"Cruz A.","year":"1991","unstructured":"Cruz A.; Coburn C.M.; Beverley S.M.; Double targeted gene replacement for creating null mutants. Proc Natl Acad Sci USA 1991,88(16),7170-7174","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1365-2958.2008.06305.x","volume":"69","author":"Sienkiewicz N.","year":"2008","unstructured":"Sienkiewicz N.; Jaros\u0142awski S.; Wyllie S.; Fairlamb A.H.; Chemical and genetic validation of dihydrofolate reductase-thymidylate synthase as a drug target in African trypanosomes. Mol Microbiol 2008,69(2),520-533","journal-title":"Mol Microbiol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/S0960-894X(99)00213-9","volume":"9","author":"Zuccotto F.","year":"1999","unstructured":"Zuccotto F.; Brun R.; Gonzalez Pacanowska D.; Ruiz Perez L.M.; Gilbert I.H.; The structure-based design and synthesis of selective inhibitors of Trypanosoma cruzi dihydrofolate reductase. Bioorg Med Chem Lett 1999,9(10),1463-1468","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/0006-2952(87)90508-9","volume":"36","author":"Scott D.A.","year":"1987","unstructured":"Scott D.A.; Coombs G.H.; Sanderson B.E.; Effects of methotrexate and other antifolates on the growth and dihydrofolate reductase activity of Leishmania promastigotes. Biochem Pharmacol 1987,36(12),2043-2045","journal-title":"Biochem Pharmacol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2174\/1568026024607427","volume":"2","author":"Barrett M.P.","year":"2002","unstructured":"Barrett M.P.; Gilbert I.H.; Perspectives for new drugs against trypanosomiasis and leishmaniasis. Curr Top Med Chem 2002,2(5),471-482","journal-title":"Curr Top Med Chem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0925-4439(02)00088-1","volume":"1587","author":"Gilbert I.H.","year":"2002","unstructured":"Gilbert I.H.; Inhibitors of dihydrofolate reductase in Leishmania and trypanosomes. Biochim Biophys Acta 2002,1587(2-3),249-257","journal-title":"Biochim Biophys Acta"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nsb0394-186","volume":"1","author":"Knighton D.R.","year":"1994","unstructured":"Knighton D.R.; Kan C.C.; Howland E.; Janson C.A.; Hostomska Z.; Welsh K.M.; Matthews D.A.; Structure of and kinetic channelling in bifunctional dihydrofolate reductase-thymidylate synthase. Nat Struct Biol 1994,1(3),186-194","journal-title":"Nat Struct Biol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0960-894X(01)00089-0","volume":"11","author":"Chowdhury S.F.","year":"2001","unstructured":"Chowdhury S.F.; Di Lucrezia R.; Guerrero R.H.; Brun R.; Goodman J.; Ruiz-Perez L.M.; Pacanowska D.G.; Gilbert I.H.; Novel inhibitors of Leishmanial dihydrofolate reductase. Bioorg Med Chem Lett 2001,11(8),977-980","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0223-5234(01)01235-1","volume":"36","author":"Zuccotto F.","year":"2001","unstructured":"Zuccotto F.; Zvelebil M.; Brun R.; Chowdhury S.F.; Di Lucrezia R.; Leal I.; Maes L.; Ruiz-Perez L.M.; Gonzalez Pacanowska D.; Gilbert I.H.; Novel inhibitors of Trypanosoma cruzi dihydrofolate reductase. Eur J Med Chem 2001,36(5),395-405","journal-title":"Eur J Med Chem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"14092","DOI":"10.1074\/jbc.M212690200","volume":"278","author":"Atreya C.E.","year":"2003","unstructured":"Atreya C.E.; Johnson E.F.; Irwin J.J.; Dow A.; Massimine K.M.; Coppens I.; Stempliuk V.; Beverley S.; Joiner K.A.; Shoichet B.K.; Anderson K.S.; A molecular docking strategy identifies Eosin B as a non-active site inhibitor of protozoal bifunctional thymidylate synthase-dihydrofolate reductase. J Biol Chem 2003,278(16),14092-14100","journal-title":"J Biol Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.2174\/1381612033453712","volume":"9","author":"McGuire J.J.","year":"2003","unstructured":"McGuire J.J.; Anticancer antifolates: current status and future directions. Curr Pharm Des 2003,9(31),2593-2613","journal-title":"Curr Pharm Des"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1128\/AAC.49.8.3234-3238.2005","volume":"49","author":"Senkovich O.","year":"2005","unstructured":"Senkovich O.; Bhatia V.; Garg N.; Chattopadhyay D.; Lipophilic antifolate trimetrexate is a potent inhibitor of Trypanosoma cruzi: prospect for chemotherapy of Chagas\u2019 disease. Antimicrob Agents Chemother 2005,49(8),3234-3238","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/prot.22115","volume":"73","author":"Schormann N.","year":"2008","unstructured":"Schormann N.; Senkovich O.; Walker K.; Wright D.L.; Anderson A.C.; Rosowsky A.; Ananthan S.; Shinkre B.; Velu S.; Chattopadhyay D.; Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function. Proteins 2008,73(4),889-901","journal-title":"Proteins"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1107\/S090744490901230X","volume":"65","author":"Senkovich O.","year":"2009","unstructured":"Senkovich O.; Schormann N.; Chattopadhyay D.; Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate. Acta Crystallogr D Biol Crystallogr 2009,65(Pt 7),704-716","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1016\/j.bmc.2010.04.020","volume":"18","author":"Schormann N.","year":"2010","unstructured":"Schormann N.; Velu S.E.; Murugesan S.; Senkovich O.; Walker K.; Chenna B.C.; Shinkre B.; Desai A.; Chattopadhyay D.; Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase. Bioorg Med Chem 2010,18(11),4056-4066","journal-title":"Bioorg Med Chem"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.bmcl.2013.12.071","volume":"24","author":"Fonseca-Berzal C.","year":"2014","unstructured":"Fonseca-Berzal C.; Rojas Ruiz F.A.; Escario J.A.; Kouznetsov V.V.; G\u00f3mez-Barrio A.; In vitro phenotypic screening of 7-chloro-4-amino(oxy)quinoline derivatives as putative anti-Trypanosoma cruzi agents. Bioorg Med Chem Lett 2014,24(4),1209-1213","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=90","first-page":"62","volume":"62","author":"Nefertiti A.S.G.","year":"2018","unstructured":"Nefertiti A.S.G.; Batista M.M.; Da Silva P.B.; Batista D.G.J.; Da Silva C.F.; Peres R.B.; Torres-Santos E.C.; Cunha-Junior E.F.; Holt E.; Boykin D.W.; Brun R.; Wenzler T.; Soeiro M.N.C.; In vitro and in vivo studies of the trypanocidal effect of novel quinolines. Antimicrob Agents Chemother 2018,62(2),62","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1021\/acsmedchemlett.8b00053","volume":"9","author":"Konstantinovi\u0107 J.","year":"2018","unstructured":"Konstantinovi\u0107 J.; Videnovi\u0107 M.; Orsini S.; Bogojevi\u0107 K.; D\u2019Alessandro S.; Scaccabarozzi D.; Terzi\u0107 Jovanovi\u0107 N.; Gradoni L.; Basilico N.; \u0160olaja B.A.; Novel aminoquinoline derivatives significantly reduce parasite load in Leishmania infantum Infected Mice. ACS Med Chem Lett 2018,9(7),629-634","journal-title":"ACS Med Chem Lett"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0968-0896(02)00046-9","volume":"10","author":"Sahu N.P.","year":"2002","unstructured":"Sahu N.P.; Pal C.; Mandal N.B.; Banerjee S.; Raha M.; Kundu A.P.; Basu A.; Ghosh M.; Roy K.; Bandyopadhyay S.; Synthesis of a novel quinoline derivative, 2-(2-methylquinolin-4-ylamino)-N-phenylacetamide--a potential antileishmanial agent. Bioorg Med Chem 2002,10(6),1687-1693","journal-title":"Bioorg Med Chem"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1128\/AAC.00700-11","volume":"56","author":"Palit P.","year":"2012","unstructured":"Palit P.; Hazra A.; Maity A.; Vijayan R.S.; Manoharan P.; Banerjee S.; Mondal N.B.; Ghoshal N.; Ali N.; Discovery of safe and orally effective 4-aminoquinaldine analogues as apoptotic inducers with activity against experimental visceral leishmaniasis. Antimicrob Agents Chemother 2012,56(1),432-445","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"11442","DOI":"10.1073\/pnas.91.24.11442","volume":"91","author":"Bello A.R.","year":"1994","unstructured":"Bello A.R.; Nare B.; Freedman D.; Hardy L.; Beverley S.M.; PTR1: a reductase mediating salvage of oxidized pteridines and methotrexate resistance in the protozoan parasite Leishmania major. Proc Natl Acad Sci USA 1994,91(24),11442-11446","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0166-6851(01)00213-4","volume":"113","author":"Cunningham M.L.","year":"2001","unstructured":"Cunningham M.L.; Beverley S.M.; Pteridine salvage throughout the Leishmania infectious cycle: implications for antifolate chemotherapy. Mol Biochem Parasitol 2001,113(2),199-213","journal-title":"Mol Biochem Parasitol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"13883","DOI":"10.1074\/jbc.272.21.13883","volume":"272","author":"Nare B.","year":"1997","unstructured":"Nare B.; Hardy L.W.; Beverley S.M.; The roles of pteridine reductase 1 and dihydrofolate reductase-thymidylate synthase in pteridine metabolism in the protozoan parasite Leishmania major. J Biol Chem 1997,272(21),13883-13891","journal-title":"J Biol Chem"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1021\/jm901059x","volume":"53","author":"Tulloch L.B.","year":"2010","unstructured":"Tulloch L.B.; Martini V.P.; Iulek J.; Huggan J.K.; Lee J.H.; Gibson C.L.; Smith T.K.; Suckling C.J.; Hunter W.N.; Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases. J Med Chem 2010,53(1),221-229","journal-title":"J Med Chem"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1073\/pnas.0704384105","volume":"105","author":"Cavazzuti A.","year":"2008","unstructured":"Cavazzuti A.; Paglietti G.; Hunter W.N.; Gamarro F.; Piras S.; Loriga M.; Allecca S.; Corona P.; McLuskey K.; Tulloch L.; Gibellini F.; Ferrari S.; Costi M.P.; Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development. Proc Natl Acad Sci USA 2008,105(5),1448-1453","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1006\/expr.1997.4207","volume":"87","author":"Hardy L.W.","year":"1997","unstructured":"Hardy L.W.; Matthews W.; Nare B.; Beverley S.M.; Biochemical and genetic tests for inhibitors of leishmania pteridine pathways. Exp Parasitol 1997,87(3),158-170","journal-title":"Exp Parasitol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1128\/AAC.00436-10","volume":"55","author":"Kaur J.","year":"2011","unstructured":"Kaur J.; Kumar P.; Tyagi S.; Pathak R.; Batra S.; Singh P.; Singh N.; In silico screening, structure-activity relationship, and biologic evaluation of selective pteridine reductase inhibitors targeting visceral leishmaniasis. Antimicrob Agents Chemother 2011,55(2),659-666","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.exppara.2008.05.005","volume":"120","author":"Kumar P.","year":"2008","unstructured":"Kumar P.; Kumar A.; Verma S.S.; Dwivedi N.; Singh N.; Siddiqi M.I.; Tripathi R.P.; Dube A.; Singh N.; Leishmania donovani pteridine reductase 1: biochemical properties and structure-modeling studies. Exp Parasitol 2008,120(1),73-79","journal-title":"Exp Parasitol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1016\/j.ejmech.2010.02.018","volume":"45","author":"Pandey V.P.","year":"2010","unstructured":"Pandey V.P.; Bisht S.S.; Mishra M.; Kumar A.; Siddiqi M.I.; Verma A.; Mittal M.; Sane S.A.; Gupta S.; Tripathi R.P.; Synthesis and molecular docking studies of 1-phenyl-4-glycosyl-dihydropyridines as potent antileishmanial agents. Eur J Med Chem 2010,45(6),2381-2388","journal-title":"Eur J Med Chem"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1021\/jm1010572","volume":"54","author":"Ferrari S.","year":"2011","unstructured":"Ferrari S.; Morandi F.; Motiejunas D.; Nerini E.; Henrich S.; Luciani R.; Venturelli A.; Lazzari S.; Cal\u00f2 S.; Gupta S.; Hannaert V.; Michels P.A.; Wade R.C.; Costi M.P.; Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase. J Med Chem 2011,54(1),211-221","journal-title":"J Med Chem"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"4454","DOI":"10.1021\/jm900414x","volume":"52","author":"Mpamhanga C.P.","year":"2009","unstructured":"Mpamhanga C.P.; Spinks D.; Tulloch L.B.; Shanks E.J.; Robinson D.A.; Collie I.T.; Fairlamb A.H.; Wyatt P.G.; Frearson J.A.; Hunter W.N.; Gilbert I.H.; Brenk R.; One scaffold, three binding modes: novel and selective pteridine reductase 1 inhibitors derived from fragment hits discovered by virtual screening. J Med Chem 2009,52(14),4454-4465","journal-title":"J Med Chem"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1111\/j.1365-2958.2006.05332.x","volume":"61","author":"Dawson A.","year":"2006","unstructured":"Dawson A.; Gibellini F.; Sienkiewicz N.; Tulloch L.B.; Fyfe P.K.; McLuskey K.; Fairlamb A.H.; Hunter W.N.; Structure and reactivity of Trypanosoma brucei pteridine reductase: inhibition by the archetypal antifolate methotrexate. Mol Microbiol 2006,61(6),1457-1468","journal-title":"Mol Microbiol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.parint.2013.01.007","volume":"62","author":"Chandrasekaran S.","year":"2013","unstructured":"Chandrasekaran S.; Dayakar A.; Veronica J.; Sundar S.; Maurya R.; An in vitro study of apoptotic like death in Leishmania donovani promastigotes by withanolides. Parasitol Int 2013,62(3),253-261","journal-title":"Parasitol Int"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3109\/14756366.2015.1088841","volume":"31","author":"Chandrasekaran S.","year":"2016","unstructured":"Chandrasekaran S.; Veronica J.; Gundampati R.K.; Sundar S.; Maurya R.; Exploring the inhibitory activity of Withaferin-A against Pteridine reductase-1 of L. donovani. J Enzyme Inhib Med Chem 2016,31(6),1029-1037","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s13104-018-3354-1","volume":"11","author":"Vadloori B.","year":"2018","unstructured":"Vadloori B.; Sharath A.K.; Prabhu N.P.; Maurya R.; Homology modelling, molecular docking, and molecular dynamics simulations reveal the inhibition of Leishmania donovani dihydrofolate reductase-thymidylate synthase enzyme by Withaferin-A. BMC Res Notes 2018,11(1),246","journal-title":"BMC Res Notes"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"17628","DOI":"10.1074\/jbc.M112.340059","volume":"287","author":"Ranjbarian F.","year":"2012","unstructured":"Ranjbarian F.; Vodnala M.; Vodnala S.M.; Rofougaran R.; Thelander L.; Hofer A.; Trypanosoma brucei thymidine kinase is tandem protein consisting of two homologous parts, which together enable efficient substrate binding. J Biol Chem 2012,287(21),17628-17636","journal-title":"J Biol Chem"},{"key":"ref=110","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003781","volume":"9","author":"Timm J.","year":"2015","unstructured":"Timm J.; Bosch-Navarrete C.; Recio E.; Nettleship J.E.; Rada H.; Gonz\u00e1lez-Pacanowska D.; Wilson K.S.; Structural and kinetic characterization of thymidine kinase from Leishmania major. PLoS Negl Trop Dis 2015,9(5)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=111","author":"Nyiri K.","year":"2016","unstructured":"Nyiri K.; Vertessy B.G.; Perturbation of genome integrity to fight pathogenic microorganisms. Biochim Biophys Acta 2016","journal-title":"Biochim Biophys Acta"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"714","DOI":"10.7326\/0003-4819-106-5-714","volume":"106","author":"Pearson R.D.","year":"1987","unstructured":"Pearson R.D.; Hewlett E.L.; Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii. Ann Intern Med 1987,106(5),714-718","journal-title":"Ann Intern Med"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1586\/14787210.3.6.849","volume":"3","author":"Patel S.N.","year":"2005","unstructured":"Patel S.N.; Kain K.C.; Atovaquone\/proguanil for the prophylaxis and treatment of malaria. Expert Rev Anti Infect Ther 2005,3(6),849-861","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/nyas.12766","volume":"1342","author":"Takala-Harrison S.","year":"2015","unstructured":"Takala-Harrison S.; Laufer M.K.; Antimalarial drug resistance in Africa: key lessons for the future. Ann N Y Acad Sci 2015,1342,62-67","journal-title":"Ann N Y Acad Sci"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1073\/pnas.94.4.1124","volume":"94","author":"Sirawaraporn W.","year":"1997","unstructured":"Sirawaraporn W.; Sathitkul T.; Sirawaraporn R.; Yuthavong Y.; Santi D.V.; Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proc Natl Acad Sci USA 1997,94(4),1124-1129","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/S0968-0896(00)00022-5","volume":"8","author":"Rastelli G.","year":"2000","unstructured":"Rastelli G.; Sirawaraporn W.; Sompornpisut P.; Vilaivan T.; Kamchonwongpaisan S.; Quarrell R.; Lowe G.; Thebtaranonth Y.; Yuthavong Y.; Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: structural basis of antifolate resistance. Bioorg Med Chem 2000,8(5),1117-1128","journal-title":"Bioorg Med Chem"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"16823","DOI":"10.1073\/pnas.1204556109","volume":"109","author":"Yuthavong Y.","year":"2012","unstructured":"Yuthavong Y.; Tarnchompoo B.; Vilaivan T.; Chitnumsub P.; Kamchonwongpaisan S.; Charman S.A.; McLennan D.N.; White K.L.; Vivas L.; Bongard E.; Thongphanchang C.; Taweechai S.; Vanichtanankul J.; Rattanajak R.; Arwon U.; Fantauzzi P.; Yuvaniyama J.; Charman W.N.; Matthews D.; Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target. Proc Natl Acad Sci USA 2012,109(42),16823-16828","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1042\/BJ20140240","volume":"461","author":"Drinkwater N.","year":"2014","unstructured":"Drinkwater N.; McGowan S.; From crystal to compound: structure-based antimalarial drug discovery. Biochem J 2014,461(3),349-369","journal-title":"Biochem J"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1021\/jm030165t","volume":"47","author":"Kamchonwongpaisan S.","year":"2004","unstructured":"Kamchonwongpaisan S.; Quarrell R.; Charoensetakul N.; Ponsinet R.; Vilaivan T.; Vanichtanankul J.; Tarnchompoo B.; Sirawaraporn W.; Lowe G.; Yuthavong Y.; Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities. J Med Chem 2004,47(3),673-680","journal-title":"J Med Chem"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nsb921","volume":"10","author":"Yuvaniyama J.","year":"2003","unstructured":"Yuvaniyama J.; Chitnumsub P.; Kamchonwongpaisan S.; Vanichtanankul J.; Sirawaraporn W.; Taylor P.; Walkinshaw M.D.; Yuthavong Y.; Insights into antifolate resistance from malarial DHFR-TS structures. Nat Struct Biol 2003,10(5),357-365","journal-title":"Nat Struct Biol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1080\/07391102.2014.979231","volume":"33","author":"Abbat S.","year":"2015","unstructured":"Abbat S.; Jain V.; Bharatam P.V.; Origins of the specificity of inhibitor P218 toward wild-type and mutant PfDHFR: a molecular dynamics analysis. J Biomol Struct Dyn 2015,33(9),1913-1928","journal-title":"J Biomol Struct Dyn"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nrd2082","volume":"5","author":"Copeland R.A.","year":"2006","unstructured":"Copeland R.A.; Pompliano D.L.; Meek T.D.; Drug-target residence time and its implications for lead optimization. Nat Rev Drug Discov 2006,5(9),730-739","journal-title":"Nat Rev Drug Discov"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1007\/s00044-012-0328-z","volume":"22","author":"Giridhar R.T.R.S.","year":"2013","unstructured":"Giridhar R.T.R.S.; \u2022; Prajapati, D.G.S., S. \u2022; Gupta, S.Y., M. R. Synthesis of novel 4,6-diaryl-2-aminopyrimidines as potential antiplasmodial agents. Med Chem Res 2013,22,3309-3315","journal-title":"Med Chem Res"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.bmcl.2013.12.009","volume":"24","author":"Adane L.","year":"2014","unstructured":"Adane L.; Bhagat S.; Arfeen M.; Bhatia S.; Sirawaraporn R.; Sirawaraporn W.; Chakraborti A.K.; Bharatam P.V.; Design and synthesis of guanylthiourea derivatives as potential inhibitors of Plasmodium falciparum dihydrofolate reductase enzyme. Bioorg Med Chem Lett 2014,24(2),613-617","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.pt.2009.04.005","volume":"25","author":"Anderson T.J.","year":"2009","unstructured":"Anderson T.J.; Patel J.; Ferdig M.T.; Gene copy number and malaria biology. Trends Parasitol 2009,25(7),336-343","journal-title":"Trends Parasitol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1128\/AAC.01793-10","volume":"55","author":"Eastman R.T.","year":"2011","unstructured":"Eastman R.T.; Dharia N.V.; Winzeler E.A.; Fidock D.A.; Piperaquine resistance is associated with a copy number variation on chromosome 5 in drug-pressured Plasmodium falciparum parasites. Antimicrob Agents Chemother 2011,55(8),3908-3916","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=127","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0020057","volume":"2","author":"Kidgell C.","year":"2006","unstructured":"Kidgell C.; Volkman S.K.; Daily J.; Borevitz J.O.; Plouffe D.; Zhou Y.; Johnson J.R.; Le Roch K.; Sarr O.; Ndir O.; Mboup S.; Batalov S.; Wirth D.F.; Winzeler E.A.; A systematic map of genetic variation in Plasmodium falciparum. PLoS Pathog 2006,2(6)","journal-title":"PLoS Pathog"},{"key":"ref=128","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000243","volume":"4","author":"Nair S.","year":"2008","unstructured":"Nair S.; Miller B.; Barends M.; Jaidee A.; Patel J.; Mayxay M.; Newton P.; Nosten F.; Ferdig M.T.; Anderson T.J.; Adaptive copy number evolution in malaria parasites. PLoS Genet 2008,4(10)","journal-title":"PLoS Genet"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.molbiopara.2007.05.005","volume":"155","author":"Ribacke U.","year":"2007","unstructured":"Ribacke U.; Mok B.W.; Wirta V.; Normark J.; Lundeberg J.; Kironde F.; Egwang T.G.; Nilsson P.; Wahlgren M.; Genome wide gene amplifications and deletions in Plasmodium falciparum. Mol Biochem Parasitol 2007,155(1),33-44","journal-title":"Mol Biochem Parasitol"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/mmi.12162","volume":"88","author":"Heinberg A.","year":"2013","unstructured":"Heinberg A.; Siu E.; Stern C.; Lawrence E.A.; Ferdig M.T.; Deitsch K.W.; Kirkman L.A.; Direct evidence for the adaptive role of copy number variation on antifolate susceptibility in Plasmodium falciparum. Mol Microbiol 2013,88(4),702-712","journal-title":"Mol Microbiol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.bmcl.2011.12.011","volume":"22","author":"Huang H.","year":"2012","unstructured":"Huang H.; Lu W.; Li X.; Cong X.; Ma H.; Liu X.; Zhang Y.; Che P.; Ma R.; Li H.; Shen X.; Jiang H.; Huang J.; Zhu J.; Design and synthesis of small molecular dual inhibitor of falcipain-2 and dihydrofolate reductase as antimalarial agent. Bioorg Med Chem Lett 2012,22(2),958-962","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"6467","DOI":"10.1016\/j.bmc.2017.10.017","volume":"25","author":"Chen W.","year":"2017","unstructured":"Chen W.; Huang Z.; Wang W.; Mao F.; Guan L.; Tang Y.; Jiang H.; Li J.; Huang J.; Jiang L.; Zhu J.; Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely. Bioorg Med Chem 2017,25(24),6467-6478","journal-title":"Bioorg Med Chem"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.1128\/AAC.02009-15","volume":"59","author":"Neville A.J.","year":"2015","unstructured":"Neville A.J.; Zach S.J.; Wang X.; Larson J.J.; Judge A.K.; Davis L.A.; Vennerstrom J.L.; Davis P.H.; Clinically available medicines demonstrating anti-toxoplasma activity. Antimicrob Agents Chemother 2015,59(12),7161-7169","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/1545109707301244","volume":"7","author":"Kongsaengdao S.","year":"2008","unstructured":"Kongsaengdao S.; Samintarapanya K.; Oranratnachai K.; Prapakarn W.; Apichartpiyakul C.; Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients. J Int Assoc Physicians AIDS Care (Chic) 2008,7(1),11-16","journal-title":"J Int Assoc Physicians AIDS Care (Chic)"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1021\/jm061027h","volume":"50","author":"Pelphrey P.M.","year":"2007","unstructured":"Pelphrey P.M.; Popov V.M.; Joska T.M.; Beierlein J.M.; Bolstad E.S.; Fillingham Y.A.; Wright D.L.; Anderson A.C.; Highly efficient ligands for dihydrofolate reductase from Cryptosporidium hominis and Toxoplasma gondii inspired by structural analysis. J Med Chem 2007,50(5),940-950","journal-title":"J Med Chem"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.1021\/jm8006933","volume":"51","author":"Gangjee A.","year":"2008","unstructured":"Gangjee A.; Qiu Y.; Li W.; Kisliuk R.L.; Potent dual thymidylate synthase and dihydrofolate reductase inhibitors: classical and nonclassical 2-amino-4-oxo-5-arylthio-substituted-6-methylthieno[2,3-d]pyrimidine antifolates. J Med Chem 2008,51(18),5789-5797","journal-title":"J Med Chem"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1021\/ml400208v","volume":"4","author":"Zaware N.","year":"2013","unstructured":"Zaware N.; Sharma H.; Yang J.; Devambatla R.K.; Queener S.F.; Anderson K.S.; Gangjee A.; Discovery of potent and selective inhibitors of Toxoplasma gondii thymidylate synthase for opportunistic infections. ACS Med Chem Lett 2013,4(12),1148-1151","journal-title":"ACS Med Chem Lett"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1039\/c3mb25530a","volume":"9","author":"Pacheco Homem D.","year":"2013","unstructured":"Pacheco Homem D.; Flores R.; Tosqui P.; de Castro Rozada T.; Abicht Basso E.; Gasparotto A.; Augusto Vicente Seixas F.; Homology modeling of dihydrofolate reductase from T. gondii bonded to antagonists: molecular docking and molecular dynamics simulations. Mol Biosyst 2013,9(6),1308-1315","journal-title":"Mol Biosyst"},{"key":"ref=139","first-page":"1161-73","volume":"22","author":"Landau M.J.","year":"2013","unstructured":"Landau M.J.; Sharma H.; Anderson K.S.; Selective peptide inhibitors of bifunctional thymidylate synthasedihydrofolate reductase from Toxoplasma gondii provide insights into domain-domain communication and allosteric regulation. Protein science a publication of the Protein Society 2013,22,1161-73","journal-title":"a publication of the Protein Society"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"7305","DOI":"10.1021\/bi400576t","volume":"52","author":"Sharma H.","year":"2013","unstructured":"Sharma H.; Landau M.J.; Vargo M.A.; Spasov K.A.; Anderson K.S.; First three-dimensional structure of Toxoplasma gondii thymidylate synthase-dihydrofolate reductase: insights for catalysis, interdomain interactions, and substrate channeling. Biochemistry 2013,52(41),7305-7317","journal-title":"Biochemistry"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.bmcl.2013.12.039","volume":"24","author":"Sharma H.","year":"2014","unstructured":"Sharma H.; Landau M.J.; Sullivan T.J.; Kumar V.P.; Dahlgren M.K.; Jorgensen W.L.; Anderson K.S.; Virtual screening reveals allosteric inhibitors of the Toxoplasma gondii thymidylate synthase-dihydrofolate reductase. Bioorg Med Chem Lett 2014,24(4),1232-1235","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.molbiopara.2007.12.005","volume":"158","author":"Thiel M.","year":"2008","unstructured":"Thiel M.; Harder S.; Wiese M.; Kroemer M.; Bruchhaus I.; Involvement of a Leishmania thymidine kinase in flagellum formation, promastigote shape and growth as well as virulence. Mol Biochem Parasitol 2008,158(2),152-162","journal-title":"Mol Biochem Parasitol"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/0305-0491(72)90138-1","volume":"43","author":"Chello P.L.","year":"1972","unstructured":"Chello P.L.; Jaffe J.J.; Comparative properties of trypanosomal and mammalian thymidine kinases. Comp Biochem Physiol B 1972,43(3),543-562","journal-title":"Comp Biochem Physiol B"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1107\/S0907444911007281","volume":"67","author":"McNicholas S.","year":"2011","unstructured":"McNicholas S.; Potterton E.; Wilson K.S.; Noble M.E.; Presenting your structures: the CCP4mg molecular-graphics software. Acta Crystallogr D Biol Crystallogr 2011,67(Pt 4),386-394","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/S0969-2126(96)00114-1","volume":"4","author":"Mol C.D.","year":"1996","unstructured":"Mol C.D.; Harris J.M.; McIntosh E.M.; Tainer J.A.; Human dUTP pyrophosphatase: uracil recognition by a beta hairpin and active sites formed by three separate subunits. Structure 1996,4(9),1077-1092","journal-title":"Structure"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/165707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T21:12:28Z","timestamp":1662153148000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/165707\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,20]]},"references-count":145,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2019,9,20]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867325666180926154329","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,20]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-01-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}